Xstim earns FDA nod for spinal fusion stimulator

Xstim earned FDA premarket application approval for its spine fusion stimulator, the company said April 16.

Advertisement

The Xstim device uses a low-energy signal to promote bone healing after spinal fusions, according to a news release. It is noninvasive and designed to streamline patient therapy management.

The device is expected to hit the market in the second quarter.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.